CK3 (vitamin C and vitamin K3) therapy was introduced in 2003 by Verrax, Delveaux, Jamison and others as a “new, non-toxic adjuvant cancer therapy.”

"It was just as good as IV Vitamin C - if not better - and it was portable, so I could take it at home or anywhere else."

IVtoGo holds advantages over in IV in destination, biocompatibiity, and duration. These three considerations reveal why and how IVtoGo provides a supremely convenient alternative to traditional IV vitamin C therapy.

The Alternative Route From the start, those seeking alternative health treatments have many hurdles to clear. There may be reluctance on the part of doctors to explore new therapies, access...

Clinical studies indicate IV vitamin C does induce cancer cell death in many contexts, but the dynamics of IV vitamin C as a cancer therapy are somewhat convoluted. For instance,...

Many high-profile celebrities and doctors have recently widened the exposure of vitamin C IV infusions. As a result, people have begun to ask whether high dose intravenous vitamin C is...